Astellas Pharma Inc.
A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.
4503 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 中央区日本橋本町二丁目５番１号
- Website:
- https://www.astellas.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Astellas Pharma Inc. is a global pharmaceutical company dedicated to improving human health by turning innovative science into value for patients. Formed in 2005 from the merger of Yamanouchi Pharmaceutical Co. and Fujisawa Pharmaceutical Co., the company engages in the research, development, manufacturing, and marketing of innovative pharmaceutical products. Astellas focuses on addressing unmet medical needs in several therapeutic areas, with a primary emphasis on oncology. Its key areas of innovation also include gene therapy, immuno-oncology, regenerative medicine, and treatments for blindness and mitochondrial diseases. The company is committed to a stable supply of reliable medicines worldwide and stands at the forefront of healthcare change.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Astellas Pharma Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-31 08:30 |
Regulatory News Service
訂正発行登録書
|
Japanese | 9.7 KB | |
| 2025-07-31 04:04 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 33.0 KB | |
| 2025-07-03 08:31 |
Regulatory News Service
訂正発行登録書
|
Japanese | 10.3 KB | |
| 2025-07-02 02:28 |
Regulatory News Service
臨時報告書
|
Japanese | 24.1 KB | |
| 2025-06-16 06:14 |
Regulatory News Service
内部統制報告書－第20期(2024/04/01－2025/03/31)
|
Japanese | 23.1 KB | |
| 2025-06-16 06:11 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2025-06-16 06:09 |
Annual Report
有価証券報告書－第20期(2024/04/01－2025/03/31)
|
Japanese | 2.5 MB | |
| 2025-02-04 07:47 |
Regulatory News Service
訂正発行登録書
|
Japanese | 9.9 KB | |
| 2025-02-04 07:40 |
Regulatory News Service
臨時報告書
|
Japanese | 19.4 KB | |
| 2025-02-04 07:39 |
Regulatory News Service
臨時報告書
|
Japanese | 20.9 KB | |
| 2024-11-06 05:52 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-11-06 05:51 |
Interim Report
半期報告書－第20期(2024/04/01－2025/03/31)
|
Japanese | 344.2 KB | |
| 2024-09-03 03:34 |
Regulatory News Service
発行登録追補書類（株券､社債券等）
|
Japanese | 96.0 KB | |
| 2024-07-19 04:20 |
Prospectus
発行登録書（株券､社債券等）
|
Japanese | 28.1 KB | |
| 2024-07-01 07:47 |
Regulatory News Service
臨時報告書
|
Japanese | 23.3 KB |
Automate Your Workflow. Get a real-time feed of all Astellas Pharma Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Astellas Pharma Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
